James Molloy
Stock Analyst at Alliance Global Partners
(0.40)
# 3,949
Out of 4,712 analysts
31
Total ratings
18.75%
Success rate
-42.05%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $13.87 | +152.34% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $2.26 | +563.72% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $4.49 | +345.43% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $14 | $0.42 | +3,235.72% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $6 → $11 | $0.39 | +2,754.92% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.74 | +136.49% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.77 | +165.25% | 1 | Jul 17, 2024 | |
| IGC IGC Pharma | Initiates: Buy | $3.5 | $0.37 | +845.95% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $0.63 | - | 1 | Jun 18, 2024 | |
| XRTX XORTX Therapeutics | Maintains: Buy | $9 → $14 | $1.12 | +1,155.61% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.39 | +2,058.27% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.28 | +485.94% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.68 | +252.11% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.93 | +760.68% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $3.52 | +98.86% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.98 | +8,063.27% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.78 | +798.88% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.88 | +1,500.00% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.82 | +1,740.49% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $0.49 | +49,374.34% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $2.28 | +6,478.95% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $0.31 | +20,061.29% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.79 | +559.63% | 1 | Oct 4, 2021 |
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $13.87
Upside: +152.34%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $2.26
Upside: +563.72%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $4.49
Upside: +345.43%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $14
Current: $0.42
Upside: +3,235.72%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $6 → $11
Current: $0.39
Upside: +2,754.92%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.74
Upside: +136.49%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.77
Upside: +165.25%
IGC Pharma
Jul 17, 2024
Initiates: Buy
Price Target: $3.5
Current: $0.37
Upside: +845.95%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $0.63
Upside: -
XORTX Therapeutics
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $1.12
Upside: +1,155.61%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.39
Upside: +2,058.27%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.28
Upside: +485.94%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.68
Upside: +252.11%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $0.93
Upside: +760.68%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $3.52
Upside: +98.86%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $0.98
Upside: +8,063.27%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $1.78
Upside: +798.88%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.88
Upside: +1,500.00%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.82
Upside: +1,740.49%
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.49
Upside: +49,374.34%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $2.28
Upside: +6,478.95%
Jun 1, 2022
Initiates: Buy
Price Target: $63
Current: $0.31
Upside: +20,061.29%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $3.79
Upside: +559.63%